SHIRAKI MASATAKA | Department of Endocrinology and Metabolism, Tokyo Metropolitan Geriatric Hospital

スポンサーリンク

概要

関連著者

もっと見る

著作論文

A Placebo-Controlled, Single-Blind Study to Determine the Appropriate Alendronate Dosage in Postmenopausal Japanese Patients with Osteopotosis
Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures
Established Osteoporosis Associated with High Mortality after Adjustment for Age and Co-Mobidities in Postmenopausal Japanese Women
Bone metabolic marker levels in residents of a rural community in Japan
Effects of 2 Years' Treatment of Osteoporosis with 1α-Hydroxy Vitamin D3 on Bone Mineral Density and Incidence of Fracture : A Placebo-Controlled, Double-Blind Prospective Study
The Relationship Between Back Pain and Future Vertebral Fracture in Postmenopausal Women
Stability of [Asu1, 7]-Eel Calcitonin and Eel Calcitonin in Vitro and in Vivo
Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures
1-34 Human Parathyroid Hormone Radioimmunoassay: Properties of Antiserum Against Synthetic 1-34 Human Parathyroid Hormone and Its Clinical Application
Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition)

スポンサーリンク